https://www.openbell.ai/ 2026-10-14T12:37:29.199Z hourly 1.0 https://www.openbell.ai/support 2026-10-14T12:37:29.199Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-14T12:37:29.199Z monthly 0.5 https://www.openbell.ai/terms 2026-10-14T12:37:29.199Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-14T12:37:29.199Z hourly 0.8 https://www.openbell.ai/news/BUUU:1791981419697 2026-10-14T12:36:59.697Z daily 0.9 https://cdn.brandfetch.io/BUUU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Brightray Science Signs LoI For Planned 10 MW AI Data Center Project In Indiana Brightray Science has signed a Letter of Intent (LOI) for a planned 10 MW AI data center project in Indiana, USA. The project aims to utilize Brightray's prefabricated data center solution and is designed to meet Tier III standards with a target annual power usage effectiveness (PUE) of below 1.2. The LOI is non-binding and will expire in 12 months unless replaced by a definitive agreement, with a purchase order expected by November 15, 2026. This project marks Brightray's entry into the U.S. market and could serve as a reference for future business expansion if finalized. https://www.openbell.ai/news/PGR:1791981395187 2026-10-14T12:36:35.187Z daily 0.9 https://cdn.brandfetch.io/PGR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Progressive shares are trading lower after the company reported mixed Q3 financial results. openbell Financial News https://www.openbell.ai/news/FBLG:1791981334949 2026-10-14T12:35:34.949Z daily 0.9 https://cdn.brandfetch.io/FBLG/w/400/h/400?c=1idopYfmtR7ZKg8QMud FibroBiologics Says IP Australia Issues Notice Of Acceptance For Australian Patent Application Titled ‘Cellular Blend For The Regeneration Of Chondrocytes Or Cartilage Type Cells’ FibroBiologics, Inc. announced that IP Australia has issued a Notice of Acceptance for its Australian Patent Application No. 2024200985, which covers methods for regenerating cartilage using a combination of fibroblasts, platelet-rich plasma, and nucleus pulposus conditioned media. The company, which is focused on developing therapeutics for chronic diseases, holds over 270 patents issued and pending. This patent acceptance may enhance its position in the biotechnology sector. https://www.openbell.ai/news/CAAP:1791981334104 2026-10-14T12:35:34.104Z daily 0.9 https://cdn.brandfetch.io/CAAP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Corporación América Airports Acquires ~5.789% Stake In Toscana Aeroporti From SOGIM For €19M, Raising Economic Interest To 68.072% openbell Financial News https://www.openbell.ai/news/INMB:1791981329879 2026-10-14T12:35:29.879Z daily 0.9 https://cdn.brandfetch.io/INMB/w/400/h/400?c=1idopYfmtR7ZKg8QMud INmune Bio And Quantum Computing Inc. Partner To Use Quantum AI To Identify New Treatment Applications For Alzheimer’s Drug XPro INmune Bio Inc. (NASDAQ: INMB) has partnered with Quantum Computing Inc. (NASDAQ: QUBT) to utilize quantum AI for identifying new treatment applications for its Alzheimer's drug XPro (XPro1595). This collaboration marks QCi's first commercial engagement in the pharmaceutical sector, combining INmune Bio's clinical research with QCi's Dirac-3S quantum optimization machine. The initiative aims to analyze clinical and biomedical datasets to uncover potential new indications and biomarkers for XPro, with possibilities for further collaboration as INmune Bio progresses in its clinical development. https://www.openbell.ai/news/AGPU:1791981318404 2026-10-14T12:35:18.404Z daily 0.9 https://cdn.brandfetch.io/AGPU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Axe Compute Collaborates With Penguin Solutions To Integrate Its Services Into Axe's Partner Network Axe Compute Inc. (NASDAQ: AGPU) has announced a strategic partnership with Penguin Solutions (NASDAQ: PENG) to integrate Penguin's technology and services into Axe's partner network. This collaboration aims to enhance Axe Compute's Build-to-Order program, which focuses on delivering enterprise-grade AI infrastructure at scale. The partnership is expected to leverage Penguin's technical expertise to accelerate Axe Compute's offerings in the AI infrastructure market. https://www.openbell.ai/news/SYPR:1791981307244 2026-10-14T12:35:07.244Z daily 0.9 https://cdn.brandfetch.io/SYPR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Sypris Solutions' Electronics Unit Receives U.S. Navy Follow-On Order For Electronic Power Supplies; Terms Not Disclosed Sypris Solutions' Electronics Unit has received a follow-on order from the U.S. Navy to produce electronic power supply modules for integration into an electronic warfare improvement program, with deliveries set to begin in 2027. The system aims to enhance capabilities for jamming incoming missiles and adapting to various threats, utilizing a software-defined approach for greater flexibility. Specific financial terms of the order were not disclosed. https://www.openbell.ai/news/SIDU:1791981294967 2026-10-14T12:34:54.967Z daily 0.9 https://cdn.brandfetch.io/SIDU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Sidus Space Secures Over $3M In Space And Defense Manufacturing Contracts In Q3 2026 Sidus Space, Inc. (NASDAQ: SIDU) announced securing over $3 million in space and defense hardware manufacturing contracts and purchase orders in Q3 2026. The company operates from a 35,000-square-foot facility in Cape Canaveral, Florida, providing end-to-end manufacturing services, including procurement and testing, under certified quality management systems. Additionally, the facility supports the design and testing of the LizzieSat® spacecraft and the Fortis VPX digital mission computing platform. https://www.openbell.ai/news/SRPT:1791981272072 2026-10-14T12:34:32.072Z daily 0.9 https://cdn.brandfetch.io/SRPT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Sarepta Says SRP-1003 Cut Disease-Causing RNA In Cell Nucleus By Up To ~80% In Preclinical Myotonic Dystrophy Model openbell Financial News https://www.openbell.ai/news/GILD:1791981260615 2026-10-14T12:34:20.615Z daily 0.9 https://cdn.brandfetch.io/GILD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Vir Biotechnology Announces Collaboration, License Agreement With Gilead To Discover, Engineer Three PRO-XTEN Dual-Masked T-Cell Engager Development Candidates Targeting Selected Solid Tumor-Associated Antigens Vir Biotechnology, Inc. has announced a collaboration and license agreement with Gilead to develop three novel PRO-XTEN dual-masked T-cell engagers targeting solid tumor-associated antigens. Under the agreement, Vir will receive $90 million upfront, including $65 million in cash and a $25 million equity investment, plus up to $135 million in preclinical milestone payments. Additionally, Vir could earn up to $1.74 billion in further milestones and royalties on net sales. This collaboration leverages Vir's expertise in T-cell engager discovery and Gilead's oncology development capabilities. https://www.openbell.ai/news/GENK:1791981256970 2026-10-14T12:34:16.970Z daily 0.9 https://cdn.brandfetch.io/GENK/w/400/h/400?c=1idopYfmtR7ZKg8QMud GEN Restaurant Group Inks $100M Letter Of Intent With Chubby Group To Sell Operations At 47 U.S. Restaurants GEN Restaurant Group, Inc. has signed a $100 million letter of intent with Chubby Group to sell operations at 47 U.S. restaurants while retaining its brand and CPG business. The transaction, approved unanimously by GEN's Board of Directors, is expected to close within 30 days and will significantly reduce GEN's lease liabilities of approximately $160 million. Following the sale, GEN anticipates eliminating its outstanding debt and may reinvest in growth, dividends, or share repurchases. https://www.openbell.ai/news/VYX:1791981225793 2026-10-14T12:33:45.793Z daily 0.9 https://cdn.brandfetch.io/VYX/w/400/h/400?c=1idopYfmtR7ZKg8QMud NCR Voyix Announces Multi-Year Agreement With Sbarro To Deploy Point-Of-Sale And Payments At Nearly 300 Locations; Terms Not Disclosed openbell Financial News https://www.openbell.ai/news/GFS:1791981203079 2026-10-14T12:33:23.079Z daily 0.9 https://cdn.brandfetch.io/GFS/w/400/h/400?c=1idopYfmtR7ZKg8QMud GlobalFoundries Tapped As Technology Provider, Operator For Two New Semiconductor Production Sites at Its New York Facility Under Japan-U.S. Initiative For Up To $21B In Funding GlobalFoundries (Nasdaq: GFS) has been selected as the technology provider and operator for two new semiconductor manufacturing facilities at its Malta, New York site, under a U.S.-Japan initiative that could provide up to $21 billion in funding. This initiative aims to enhance semiconductor manufacturing in the U.S., strengthen supply chains, and meet rising demand in sectors such as automotive and industrial. Japan will supply the investment, while GlobalFoundries will leverage its technology and operational expertise. https://www.openbell.ai/news/NWCL:1791981192170 2026-10-14T12:33:12.170Z daily 0.9 https://cdn.brandfetch.io/NWCL/w/400/h/400?c=1idopYfmtR7ZKg8QMud newcleo Opens Its €10M Nuclear Fuel Process Assembly Storage Training And Enhanced Reality Center In France newcleo has inaugurated its €10 million FASTER center in France, designed to develop and test technologies for future MOX fuel manufacturing. The facility features seven test facilities that cover essential stages of the fuel manufacturing process. This center aims to validate and optimize manufacturing processes, marking a significant step in de-risking newcleo's advanced MOX fuel program and supporting the establishment of planned fuel manufacturing facilities. https://www.openbell.ai/news/RARE:1791981185581 2026-10-14T12:33:05.581Z daily 0.9 https://cdn.brandfetch.io/RARE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Ultragenyx Announces $203M Deal To Sell Priority Review Voucher To Unnamed Buyer openbell Financial News https://www.openbell.ai/news/IMAX:1791981172390 2026-10-14T12:32:52.390Z daily 0.9 https://cdn.brandfetch.io/IMAX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wedbush Maintains Outperform on Imax, Raises Price Target to $60 Wedbush analyst Alicia Reese has maintained an Outperform rating on Imax (NYSE: IMAX) and increased the price target from $54 to $60. This adjustment reflects a positive outlook for the company's performance in the market. https://www.openbell.ai/news/GURE:1791981148327 2026-10-14T12:32:28.327Z daily 0.9 https://cdn.brandfetch.io/GURE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Gulf Resources Receives Approval From Shouguang Municipal Government To Resume Production At Its Factories No. 2 And No.10 Gulf Resources, Inc. has received approval from the Shouguang Municipal Government to resume production at its Factories No. 2 and No. 10. The company plans to begin preparation work immediately, with test and trial production expected to be completed in the fourth quarter of 2026, and revenue generation anticipated in the first half of 2027. This resumption is projected to increase the company's annual production capacity by more than 20%. https://www.openbell.ai/news/PPCB:1791981122790 2026-10-14T12:32:02.790Z daily 0.9 https://cdn.brandfetch.io/PPCB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Propanc Biopharma Says Published Pilot Study Showed 85.9% Mean Tumor Weight Reduction With PRP In Pancreatic Cancer Animal Model openbell Financial News https://www.openbell.ai/news/NEOV:1791981098982 2026-10-14T12:31:38.982Z daily 0.9 https://cdn.brandfetch.io/NEOV/w/400/h/400?c=1idopYfmtR7ZKg8QMud NeoVolta Inks $10M Master Supply Agreement With Lion Power For Its Energy Storage Offering NeoVolta Inc. (NASDAQ: NEOV) has signed a Master Supply Agreement with Lion Power LLC, committing to a minimum purchase of nearly $10 million for energy storage solutions through 2027. The agreement includes initial purchase orders exceeding $4 million, with battery capacity shipments scheduled for Q4 2026, marking NeoVolta Power's first commercial deliveries. The battery packs will be integrated into Lion Power's PowerBase™ system, aimed at optimizing energy management for facility operators. https://www.openbell.ai/news/U:1791981084948 2026-10-14T12:31:24.948Z daily 0.9 https://cdn.brandfetch.io/U/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wedbush Maintains Outperform on Unity Software, Raises Price Target to $55 Wedbush analyst Alicia Reese has maintained an 'Outperform' rating on Unity Software (NYSE: U) and raised the price target from $50 to $55. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/MU:1791981075142 2026-10-14T12:31:15.142Z daily 0.9 https://cdn.brandfetch.io/MU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Social Media Discussion: $MU Main sentiment: Cautiously bullish. Key theme/event: Discussions on stock positions and trading strategies for October 14, 2026, with a focus on individual stock risks. https://www.openbell.ai/news/SPCX:1791981012053 2026-10-14T12:30:12.053Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/Ryanairs-CEO-Thanks-Musk-For-The-Publici.jpg?width=250&height=187 Elon Musk Is Pushing Aggressively To Bring SpaceX’s Starlink to India — Indian Rival Says He’s ‘Significantly Ahead’ of SPCX in Approval Queue Elon Musk's SpaceX is actively seeking to launch its Starlink service in India, but Bharti Enterprises Chairman Sunil Bharti Mittal claims his satellite venture has been waiting longer for regulatory approvals and is 'significantly ahead' in the approval queue, having applied five years ago. Musk has criticized unnamed 'oligarchs' for blocking Starlink's entry, a claim the Indian communications ministry has dismissed as baseless. Despite the competition, Starlink has formed partnerships with both Bharti Airtel and Jio to distribute its services once approvals are granted. https://www.openbell.ai/news/GME:1791980910544 2026-10-14T12:28:30.544Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/Helena--Montana---January-31--2021-Games.jpg?width=250&height=187 Ryan Cohen Keeps Buying GameStop Stock as Share Prices Increase. Here’s What He’s Spent Recently Ryan Cohen, CEO of GameStop Corp. (NYSE: GME), purchased 844,130 shares at prices between $26.75 and $27.00, totaling approximately $22.8 million. This marks his fifth purchase since September 10, amounting to about 4.1 million shares and roughly $97 million in total. GameStop shares are currently near a 52-week high of $27, having increased 26% over the past 30 days and more than 30% this year. As of now, GameStop shares are trading at $27.61, reflecting a 1.43% increase. https://www.openbell.ai/news/BEAM:1791980881604 2026-10-14T12:28:01.604Z daily 0.9 https://cdn.brandfetch.io/BEAM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wedbush Reiterates Outperform on Beam Therapeutics, Maintains $65 Price Target Wedbush analyst David Nierengarten has reiterated an Outperform rating on Beam Therapeutics (NASDAQ: BEAM) and maintained a price target of $65 for the stock. https://www.openbell.ai/news/KTB:1791980877679 2026-10-14T12:27:57.679Z daily 0.9 https://cdn.brandfetch.io/KTB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Jefferies Upgrades Kontoor Brands to Buy, Raises Price Target to $89 Jefferies analyst Blake Anderson has upgraded Kontoor Brands (NYSE: KTB) from a Hold to a Buy rating. The price target for the stock has been raised from $82 to $89. https://www.openbell.ai/news/TXRH:1791980781946 2026-10-14T12:26:21.946Z daily 0.9 https://cdn.brandfetch.io/TXRH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Jefferies Upgrades Texas Roadhouse to Buy, Raises Price Target to $190 Jefferies analyst Andy Barish has upgraded Texas Roadhouse (NASDAQ: TXRH) from Hold to Buy. The price target for the stock has been raised from $186 to $190. https://www.openbell.ai/news/CVS:1791980764867 2026-10-14T12:26:04.867Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/CVS-Pharmacy.jpg?width=250&height=187 CVS Agrees to $315 Million Settlement Over Alleged Illegal Opioid Prescriptions CVS Health Inc. has agreed to a $315 million settlement to resolve allegations of illegally dispensing opioids and billing government healthcare programs for invalid prescriptions. The settlement addresses violations of the Controlled Substances Act and the False Claims Act from October 2013 to December 2025, as outlined in a federal complaint filed in December 2024. As part of the agreement, CVS will implement new compliance measures with the Drug Enforcement Administration, including monitoring dispensing patterns and evaluating suspicious prescribers. Following the news, CVS shares rose 0.29% to $87.80 in premarket trading. https://www.openbell.ai/news/ACN:1791980687923 2026-10-14T12:24:47.923Z daily 0.9 https://cdn.brandfetch.io/ACN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Accenture shares are trading higher after the company outlined a multi-year growth plan at its Investor Day, targeting mid-single-digit revenue growth, continued margin expansion, strong free cash flow, and substantial shareholder returns through dividends and buybacks. openbell Financial News https://www.openbell.ai/news/PGR:1791980676450 2026-10-14T12:24:36.450Z daily 0.9 https://cdn.brandfetch.io/PGR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Progressive Reports September EPS $1.08, Up 109% YoY, And Net Premiums Written $7.255B Up From $7.128B YoY openbell Financial News https://www.openbell.ai/news/EAT:1791980660360 2026-10-14T12:24:20.360Z daily 0.9 https://cdn.brandfetch.io/EAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Jefferies Upgrades Brinker International to Buy, Raises Price Target to $255 Jefferies analyst Andy Barish has upgraded Brinker International (NYSE: EAT) from Hold to Buy. The price target for the stock has been raised from $230 to $255. https://www.openbell.ai/news/CYCU:1791980527503 2026-10-14T12:22:07.503Z daily 0.9 https://cdn.brandfetch.io/CYCU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cycurion Announces Its Relaunch As Predictive Cybersecurity Firm Cycurion, Inc. (NASDAQ: CYCU) has announced its relaunch as a predictive cybersecurity firm, focusing on proactive measures to prevent cyber attacks. The company has assembled a new team of experts from the U.S. Intelligence Community and the private sector to develop AI-driven technology aimed at detecting potential threats before they occur. The first capability of this new approach is expected to be released in the coming weeks. https://www.openbell.ai/news/SCHW:1791980494111 2026-10-14T12:21:34.111Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/Charles-Schwab-Corporation-Schd-Financia.jpg?width=250&height=187 How To Earn $500 A Month From Charles Schwab Stock Ahead Of Q3 Earnings Charles Schwab (NYSE: SCHW) is set to release its Q3 earnings report on October 15, with analysts expecting earnings of $1.66 per share and quarterly revenue of $7.19 billion, up from $6.13 billion last year. The company's current annual dividend yield is 1.33%, equating to a quarterly dividend of 32 cents per share. Shares of Charles Schwab closed at $95.94, down 1.2%, and Truist Securities has maintained a Buy rating while lowering the price target from $130 to $125. https://www.openbell.ai/news/ALB:1791980480100 2026-10-14T12:21:20.100Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/Albemarle-Stuttgart--Germany---06-12-202.jpg?width=250&height=187 This Albemarle Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday Mizuho analyst John Roberts upgraded Albemarle Corp (NYSE: ALB) from Neutral to Outperform, maintaining a price target of $130, while the stock closed at $97.65 on Tuesday. This upgrade is part of a broader trend where several companies received analyst upgrades, including Liquidia Corp, Weyerhaeuser Co, and Ralliant Corp, each with new price targets set by their respective analysts. https://www.openbell.ai/news/LFWD:1791980457818 2026-10-14T12:20:57.818Z daily 0.9 https://cdn.brandfetch.io/LFWD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Lifeward Announces Publication Of Long-Term Study On User Experience Of Its ReWalk Personal Exoskeleton In 'Spinal Cord Series And Cases' Lifeward announced the publication of a long-term study on the ReWalk Personal Exoskeleton, which provides evidence on its safety and user experience for individuals with chronic paraplegia. The study, published in 'Spinal Cord Series and Cases', evaluated seven participants over a median usage of 33 months, showing no reported falls or exoskeleton-related fractures. Key findings included sustained utilization with six participants walking over 3,000 steps per month, high user satisfaction scores, and reported improvements in bowel and bladder management and pain. The ReWalk system is FDA-cleared in the U.S. and CE Marked in Europe, and is covered by Medicare for eligible users. https://www.openbell.ai/news/IREN:1791980383388 2026-10-14T12:19:43.388Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/Chinas-Exports-Surge-Despite-US-Shortfal.jpg?width=250&height=187 Jim Cramer Skips IREN: ‘The Only One That I Trust’ Is a Different Neocloud Jim Cramer recommended holding Element Solutions Inc (NYSE: ESI) after Barclays initiated coverage with an Overweight rating and a price target of $53. Cramer expressed trust in CoreWeave over IREN Limited (NASDAQ: IREN), which has entered a multi-year cloud compute deal with Anthropic. Additionally, he suggested buying MasTec, Inc. (NYSE: MTZ), despite a recent price target reduction from Stifel analyst Brian Brophy, and noted that Waste Management, Inc. (NYSE: WM) is a better company than Waste Connections, Inc. (NYSE: WCN). https://www.openbell.ai/news/BLK:1791980340536 2026-10-14T12:19:00.536Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/Konskie--Poland---November-12--2024-Blac.jpg?width=250&height=187 BlackRock's Assets Swell to $15.5 Trillion, CEO Signals 'Accelerating Momentum' BlackRock Inc. reported a 19% year-over-year revenue increase to $7.75 billion for the third quarter, surpassing analyst estimates. The company's assets under management rose 15% to $15.49 trillion, driven by $205 billion in quarterly net inflows. Adjusted earnings per share reached $15.93, exceeding the consensus estimate of $14.13. BlackRock's stock rose 3.18% to $1100.00 in premarket trading following the announcement. https://www.openbell.ai/news/BAC:1791980137249 2026-10-14T12:15:37.249Z daily 0.9 https://cdn.brandfetch.io/BAC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bank of America shares are trading lower after the company reported worse-than-expected Q3 financial results. openbell Financial News https://www.openbell.ai/news/CDT:1791980124267 2026-10-14T12:15:24.267Z daily 0.9 https://cdn.brandfetch.io/CDT/w/400/h/400?c=1idopYfmtR7ZKg8QMud CDT Equity Announces Patent Filing From Sarborg Limited For Its Intellectual Property Covering Novel Solid Forms Of Respiratory Medicine CDT Equity Inc. (NASDAQ: CDT) has acknowledged a patent filing from Sarborg Limited for novel solid forms of a first-in-class respiratory medicine, targeting a market worth over $20 billion annually. CDT owns 1,290 shares in Sarborg, equating to a 22.7% stake, with Sarborg's recent capital raise valuing CDT's investment at approximately $161 million, based on a share price of $125,000. https://www.openbell.ai/news/SPTX:1791980071095 2026-10-14T12:14:31.095Z daily 0.9 https://cdn.brandfetch.io/SPTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Canaccord Genuity Initiates Coverage On Seaport Therapeutics with Buy Rating, Announces Price Target of $28 Canaccord Genuity has initiated coverage on Seaport Therapeutics (NASDAQ: SPTX) with a Buy rating. The firm has set a price target of $28 for the company's stock. https://www.openbell.ai/news/TAK:1791980010296 2026-10-14T12:13:30.296Z daily 0.9 https://cdn.brandfetch.io/TAK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Takeda Reports TAK-881 Cuts Infusion Volume 50%, Single-Site Infusion Time 42.6% Vs. HyQvia In Phase 2/3 Immunodeficiency Trial openbell Financial News https://www.openbell.ai/news/ALB:1791979987214 2026-10-14T12:13:07.214Z daily 0.9 https://cdn.brandfetch.io/ALB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Albemarle shares are trading higher after Mizuho upgraded the stock from Neutral to Outperform rating and maintained the price target at $130. openbell Financial News https://www.openbell.ai/news/SPCE:1791979947212 2026-10-14T12:12:27.212Z daily 0.9 https://cdn.brandfetch.io/SPCE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Virgin Galactic Inks 24-Month Agreement With Space Warfare Directorate Over Use Of Virgin Galactic's Spaceship Virgin Galactic (NYSE: SPCE) has entered into a 24-month Cooperative Research and Development Agreement (CRADA) with the Air Force Research Laboratory's Space Warfare Directorate. The agreement aims to utilize Virgin Galactic's next-generation Spaceship to capture space weather data and enhance understanding of its impact on space-based infrastructure. Researchers will assess the integration of sensor systems with the Spaceship for data collection during flights. https://www.openbell.ai/news/DLXY:1791979940027 2026-10-14T12:12:20.027Z daily 0.9 https://cdn.brandfetch.io/DLXY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Delixy Holdings Says It Received Nasdaq Notice Of Regained Compliance With Minimum Bid Price Rule openbell Financial News https://www.openbell.ai/news/LQDA:1791979911329 2026-10-14T12:11:51.329Z daily 0.9 https://cdn.brandfetch.io/LQDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Liquidia shares are trading higher after the company announced a global settlement agreement with United Therapeutics, resolving all pending litigation and ensuring YUTREPIA remains available to PAH patients without disruption. openbell Financial News https://www.openbell.ai/news/MXCT:1791979809586 2026-10-14T12:10:09.586Z daily 0.9 https://cdn.brandfetch.io/MXCT/w/400/h/400?c=1idopYfmtR7ZKg8QMud MaxCyte Reports Preliminary Q3 Core Revenue Of ~$8.1M, Up 26% YoY; Raises FY26 Revenue Guidance To ~$34M, Core Business Revenue Outlook To ~$28M MaxCyte, Inc. (NASDAQ: MXCT) reported preliminary core revenue of approximately $8.1 million for Q3 2026, marking a 26% increase year-over-year. The company has raised its full-year 2026 revenue guidance to approximately $34 million, up from the previous estimate of $30 million to $32 million, with core business revenue expected to be around $28 million. Additionally, SPL Program-related revenue is projected at approximately $6 million, an increase from the prior guidance of $5 million. https://www.openbell.ai/news/AMPX:1791979746057 2026-10-14T12:09:06.057Z daily 0.9 https://cdn.brandfetch.io/AMPX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Canaccord Genuity Initiates Coverage On Amprius Technologies with Buy Rating, Announces Price Target of $14 Canaccord Genuity analyst George Gianarikas has initiated coverage on Amprius Technologies (NYSE: AMPX) with a Buy rating. The firm has set a price target of $14 for the company's stock. https://www.openbell.ai/news/EMAT:1791979732241 2026-10-14T12:08:52.241Z daily 0.9 https://cdn.brandfetch.io/EMAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Evolution Metals & Technologies Reaffirms FY27 Sales Guidance Of $400M-$460M; Expects To Begin Acquiring Equipment To Produce Samarium Cobalt Magnets By Mid-2027; Confirms Will Respond To U.S. Army’s Sources Sought Notice For Rare Earth Magnets Evolution Metals & Technologies Corp. (NASDAQ: EMAT) reaffirmed its fiscal 2027 revenue guidance of $400 million to $460 million and plans to begin acquiring equipment for samarium cobalt (SmCo) magnet production by mid-2027. The company estimates that its portfolio of eight sintered neodymium-iron-boron (NdFeB) magnet grades accounts for approximately 75% of global revenue in this segment. EM&T is also responding to a U.S. Army sources sought notice for rare earth magnets, highlighting its strategic focus on defense-related applications. https://www.openbell.ai/news/ATRA:1791979703455 2026-10-14T12:08:23.455Z daily 0.9 https://cdn.brandfetch.io/ATRA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Atara Biotherapeutics' Partner Pierre Fabre Pharmaceuticals Receives FDA Acceptance To Refile Biologics License Application For Tabelecleucel To Treat Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease Atara Biotherapeutics' partner, Pierre Fabre Pharmaceuticals, has received FDA acceptance for the resubmission of the Biologics License Application (BLA) for tabelecleucel, aimed at treating Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD) in patients aged two years and older. The BLA is classified as a Class 2 Resubmission, with a target action date set for March 31, 2027. https://www.openbell.ai/news/DXR:1791979688959 2026-10-14T12:08:08.959Z daily 0.9 https://cdn.brandfetch.io/DXR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Daxor Announces New Clinical Studies Validate BVA Technology In High-Acuity Heart Failure Populations To Enhance Care At HFSA 2026 Annual Scientific Meeting Daxor Corporation (NASDAQ: DXR) announced strong clinician interest and validation of its blood volume analysis (BVA™) technology at the HFSA 2026 Annual Scientific Meeting. New clinical studies demonstrated that BVA significantly improves diagnostic precision in high-acuity heart failure patients, revealing issues often missed by standard examinations. One study showed that BVA could optimize medical therapy in severe heart failure patients, leading to a statistically significant improvement in patient diuresis (p = 0.02). Another study highlighted BVA's ability to diagnose Plasma Volume Reserve depletion, enhancing clinical decision-making and treatment outcomes. https://www.openbell.ai/news/AEP:1791979588075 2026-10-14T12:06:28.075Z daily 0.9 https://cdn.brandfetch.io/AEP/w/400/h/400?c=1idopYfmtR7ZKg8QMud AEP Plans $4B Investment In 702-MW Wyoming Fuel Cell Project Under 20-Year Power Deal With Google American Electric Power (AEP) plans to invest around $4 billion in a 702-megawatt fuel cell generation project in Wyoming, supported by a 20-year power purchase agreement with Google. The project, primarily owned by AEP, aims to meet the increasing energy demands of large-scale customers. Construction is set to begin in 2026, with the facility expected to be operational by the end of 2028.